Market capitalization | $6.21b |
Enterprise Value | $5.80b |
P/E (TTM) P/E ratio | 1,146.89 |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 8.22 |
P/S ratio (TTM) P/S ratio | 8.81 |
P/B ratio (TTM) P/B ratio | 9.73 |
Revenue growth (TTM) Revenue growth | 34.14% |
Revenue (TTM) Revenue | $705.71m |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
20 Analysts have issued a Inspire Medical Systems, Inc. forecast:
20 Analysts have issued a Inspire Medical Systems, Inc. forecast:
Dec '23 | |
Current assets | 594 594 |
Fixed assets | 83 83 |
Total Assets | 677 677 |
Dec '23 | |
Equity | 573 573 |
Debt capital | 104 104 |
Total Capital | 677 677 |
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Head office | United States |
CEO | Timothy Herbert |
Employees | 1,011 |
Founded | 2007 |
Website | www.inspiresleep.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.